I think there is room for a little disappointment that there is not more substance to the announcement;
the MSF clinical study is nothing to get excited about as it will probably become redundant as soon as FDA approves - as I'm sure they will.
However, that MSF are named, and have declared support is excellent. They already know ResApp works for them.
All is good.
Very good news; don't think the trading halt was warranted.
I think there is room for a little disappointment that there is...
-
- There are more pages in this discussion • 82 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $176.2M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| RAP (ASX) Chart |
Day chart unavailable